BriaCell Therapeutics Corp. (BCT) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Rapid Dose Therapeutics Corp.

Avicanna, Inc.

Microbix Biosystems, Inc.

Ceapro, Inc.

Cardiol Therapeutics, Inc.

Oncolytics Biotech, Inc.

Medicenna Therapeutics Corp.

Sernova Corp.

BriaCell Therapeutics Corp.

FSD Pharma, Inc.

Cognetivity Neurosciences Ltd.

Why is BriaCell Therapeutics Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is BriaCell Therapeutics Corp. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

BriaCell Therapeutics Corp.

-100.0%

0.01

1916.67%

S&P/TSX 60

21.87%

1.54

14.62%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-247.02%

EBIT to Interest (avg)

-18.00

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.00

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.67%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.08

EV to EBIT

-0.11

EV to EBITDA

-0.11

EV to Capital Employed

3.36

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-3117.01%

ROE (Latest)

-102.40%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Bearish

OBV

Mildly Bullish

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at CAD -23.14 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-16What is not working for the Company

INTEREST(9M)

At CAD 0.05 MM has Grown at inf%

PRE-TAX PROFIT(Q)

At CAD -11.52 MM has Fallen at -61.79%

NET PROFIT(Q)

At CAD -11.4 MM has Fallen at -61.05%

OPERATING CASH FLOW(Y)

Lowest at CAD -40.48 MM

Here's what is working for BriaCell Therapeutics Corp.

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for BriaCell Therapeutics Corp.

Interest

At CAD 0.05 MM has Grown at inf%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Pre-Tax Profit

At CAD -11.52 MM has Fallen at -61.79%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -11.4 MM has Fallen at -61.05%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Operating Cash Flow

Lowest at CAD -40.48 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)